{"id":"https://openalex.org/W4290803826","doi":"https://doi.org/10.1080/08923973.2022.2112222","title":"A comparison of panitumumab and cetuximab in the treatment of KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis","display_name":"A comparison of panitumumab and cetuximab in the treatment of KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis","alternate_titles":[],"publication_year":2022,"publication_date":"2022-08-11","ids":{"openalex":"https://openalex.org/W4290803826","doi":"https://doi.org/10.1080/08923973.2022.2112222","pmid":"https://pubmed.ncbi.nlm.nih.gov/35950851"},"language":"en","primary_location":{"id":"doi:10.1080/08923973.2022.2112222","doi":"https://doi.org/10.1080/08923973.2022.2112222","is_oa":false,"landing_page_url":"https://doi.org/10.1080/08923973.2022.2112222","pdf_url":null,"source":{"id":"https://openalex.org/S16829457","display_name":"Immunopharmacology and Immunotoxicology","issn_l":"0892-3973","issn":["0892-3973","1532-2513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunopharmacology and Immunotoxicology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4290803826"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100392626","display_name":"Tong Liu","orcid":"https://orcid.org/0000-0001-9234-1328","observed_orcids":["https://orcid.org/0000-0001-9234-1328"]},"institutions":[{"id":"https://openalex.org/I4210103956","display_name":"Third Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/01f77gp95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103956"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tong Liu","raw_affiliation_strings":["Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China","institution_ids":["https://openalex.org/I4210103956"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054482344","display_name":"Shuai Jiang","orcid":"https://orcid.org/0000-0003-1235-6269","observed_orcids":["https://orcid.org/0000-0003-1235-6269"]},"institutions":[{"id":"https://openalex.org/I4210103956","display_name":"Third Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/01f77gp95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103956"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shuai Jiang","raw_affiliation_strings":["Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China","institution_ids":["https://openalex.org/I4210103956"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Xue Teng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103956","display_name":"Third Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/01f77gp95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103956"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xue Teng","raw_affiliation_strings":["Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China","institution_ids":["https://openalex.org/I4210103956"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100308269","display_name":"Lu Zhong","orcid":"https://orcid.org/0009-0004-0910-0515","observed_orcids":["https://orcid.org/0009-0004-0910-0515"]},"institutions":[{"id":"https://openalex.org/I4210103956","display_name":"Third Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/01f77gp95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103956"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lu Zhong","raw_affiliation_strings":["Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China","institution_ids":["https://openalex.org/I4210103956"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100333921","display_name":"Mengmeng Liu","orcid":"https://orcid.org/0000-0003-4422-7314","observed_orcids":["https://orcid.org/0000-0003-4422-7314"]},"institutions":[{"id":"https://openalex.org/I4210103956","display_name":"Third Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/01f77gp95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103956"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mengmeng Liu","raw_affiliation_strings":["Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China","institution_ids":["https://openalex.org/I4210103956"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028093136","display_name":"Yao Jin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103956","display_name":"Third Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/01f77gp95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103956"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yao Jin","raw_affiliation_strings":["Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China","institution_ids":["https://openalex.org/I4210103956"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101765231","display_name":"Mei Dong","orcid":"https://orcid.org/0000-0002-7482-1499","observed_orcids":["https://orcid.org/0000-0002-7482-1499"]},"institutions":[{"id":"https://openalex.org/I4210103956","display_name":"Third Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/01f77gp95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103956"]}],"countries":["CN"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Mei Dong","raw_affiliation_strings":["Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China","institution_ids":["https://openalex.org/I4210103956"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5101765231"],"corresponding_institution_ids":["https://openalex.org/I4210103956"],"apc_list":null,"apc_paid":null,"fwci":0.4228,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.43488177,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":98},"biblio":{"volume":"45","issue":"1","first_page":"1","last_page":"9"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/panitumumab","display_name":"panitumumab","score":0.9459999799728394},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":1.0},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9649999737739563},{"id":"https://openalex.org/keywords/kras-wild-type","display_name":"KRAS wild-type","score":0.8960000276565552},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.7639999985694885},{"id":"https://openalex.org/keywords/anti-egfr-antibody-therapy","display_name":"anti-EGFR antibody therapy","score":0.7369999885559082},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8140000104904175},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9980000257492065},{"id":"https://openalex.org/keywords/acneiform-rash","display_name":"acneiform rash","score":0.7910000085830688},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.8870000243186951},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5260000228881836},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.4880000054836273},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6140000224113464},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.5249999761581421},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.4320000112056732},{"id":"https://openalex.org/keywords/time-to-response","display_name":"time to response","score":0.6389999985694885},{"id":"https://openalex.org/keywords/treatment-response-time","display_name":"treatment response time","score":0.38499999046325684}],"concepts":[{"id":"https://openalex.org/C2778332735","wikidata":"https://www.wikidata.org/wiki/Q417775","display_name":"Panitumumab","level":5,"score":0.9720425009727478},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.9703596830368042},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8459559679031372},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.713831901550293},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.705765426158905},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.6815491914749146},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6615766286849976},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.6468785405158997},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.537981390953064},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.5147650241851807},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.47766122221946716},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.34628134965896606},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29386478662490845},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.1971694529056549}],"mesh":[{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000077544","descriptor_name":"Panitumumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010304","descriptor_name":"Paronychia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D010304","descriptor_name":"Paronychia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012004","descriptor_name":"Rectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D016283","descriptor_name":"Proto-Oncogene Proteins p21(ras)","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016283","descriptor_name":"Proto-Oncogene Proteins p21(ras)","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/08923973.2022.2112222","doi":"https://doi.org/10.1080/08923973.2022.2112222","is_oa":false,"landing_page_url":"https://doi.org/10.1080/08923973.2022.2112222","pdf_url":null,"source":{"id":"https://openalex.org/S16829457","display_name":"Immunopharmacology and Immunotoxicology","issn_l":"0892-3973","issn":["0892-3973","1532-2513"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunopharmacology and Immunotoxicology","raw_type":"journal-article"},{"id":"pmid:35950851","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35950851","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Immunopharmacology and immunotoxicology","raw_type":"Meta-Analysis"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W2116432082","https://openalex.org/W2125435699","https://openalex.org/W2131059542","https://openalex.org/W2235523093","https://openalex.org/W2465233115","https://openalex.org/W2527683789","https://openalex.org/W2567289819","https://openalex.org/W2591303105","https://openalex.org/W2712978371","https://openalex.org/W2790215695","https://openalex.org/W2898337610","https://openalex.org/W2913991184","https://openalex.org/W2969648360","https://openalex.org/W3022903699","https://openalex.org/W3035430680","https://openalex.org/W3037750477","https://openalex.org/W3092740879","https://openalex.org/W3117652431","https://openalex.org/W3130224122","https://openalex.org/W3176535116"],"related_works":["https://openalex.org/W2908163567","https://openalex.org/W2590480900","https://openalex.org/W1799531120","https://openalex.org/W2465233115","https://openalex.org/W2790215695","https://openalex.org/W2045888711","https://openalex.org/W2143911880","https://openalex.org/W3030160958","https://openalex.org/W2070975285","https://openalex.org/W3116599757"],"abstract_inverted_index":{"Aim":[0],"Cetuximab":[1],"and":[2,43,47,60,65,87,97,101,114,155,162,177,184,240,305,355,361,382],"panitumumab":[3,48,66,102,163,185,299,362,380],"are":[4,33,49],"common":[5],"antibodies":[6],"against":[7],"epidermal":[8],"growth":[9],"factor":[10],"receptor":[11],"(EGFR)":[12],"that":[13,302],"can":[14],"be":[15,36],"used":[16,129],"in":[17,40,67,103,164,174,231,297,310,352,364,378,389],"combination":[18],"with":[19,142],"chemotherapy":[20],"for":[21,135],"the":[22,41,58,68,75,95,104,132,151,165,298,311,358,365,372,379,383,390],"treatment":[23,69,105,166,366],"of":[24,45,63,70,80,99,106,119,160,167,233,293,303,367,374,385],"metastatic":[25],"colorectal":[26],"cancer":[27],"(mCRC).":[28],"Although":[29],"these":[30],"two":[31],"drugs":[32],"considered":[34],"to":[35,56,90,94,130,149],"very":[37],"similar,":[38],"differences":[39],"efficacy":[42,96],"safety":[44,98],"cetuximab":[46,64,100,161,182,312,359,391],"still":[50],"unclear.":[51],"We":[52,72,220],"conducted":[53],"this":[54,136],"meta-analysis":[55],"explore":[57],"effects":[59],"adverse":[61,370],"reactions":[62],"mCRC.Methods":[71],"searched":[73],"PubMed,":[74],"Cochrane":[76],"Library,":[77],"Embase,":[78],"Web":[79],"Science,":[81],"China":[82],"national":[83],"knowledge":[84],"infrastructure":[85],"(CNKI)":[86],"WanFang":[88],"databases":[89],"identify":[91],"records":[92],"related":[93],"mCRC.":[107,368],"The":[108,117,291],"search":[109],"terms":[110],"were":[111,147,308],"\u201ccetuximab,\u201d":[112],"\u201cpanitumumab,\u201d":[113],"\u201ccolorectal":[115],"cancer.\u201d":[116],"deadline":[118],"searching":[120],"was":[121,128,170,295,348,376,387],"April":[122],"2022.":[123],"Review":[124],"manager":[125],"5.4":[126],"software":[127],"perform":[131],"statistical":[133,226],"analysis":[134],"meta-analysis.":[137],"Pooled":[138],"hazard":[139],"ratio":[140],"(HR)":[141],"95%":[143,191,202,213,248,261,272,284,318,329,340],"confidence":[144],"intervals":[145],"(CI)":[146],"calculated":[148],"evaluate":[150],"overall":[152],"survival":[153,158],"(OS)":[154],"progression":[156],"free":[157],"(PFS)":[159],"mCRC.Results":[168],"There":[169,347],"no":[171,349],"significant":[172,350],"difference":[173,227,351],"OS,":[175,353],"PFS,":[176],"response":[178],"rate":[179],"(RR)":[180],"between":[181,228,357],"arm":[183,186,360,363],"(OS:":[187],"HR":[188,199],"=":[189,193,196,200,204,207,211,215,218,246,250,253,259,263,266,270,274,277,282,286,289,316,320,323,327,338,342,345],"0.91,":[190],"CI":[192,203,214,249,262,273,285,319,330,341],"0.81\u20131.03,":[194],"p":[195,206,217,252,265,276,288,322,332,344],".14;":[197],"PFS:":[198],"0.92,":[201],"0.83\u20131.02,":[205],".11;":[208],"RR:":[209],"OR":[210,245,258,269,281,315,326,337],"1.22,":[212],"0.96\u20131.61,":[216],".14).":[219],"also":[221],"did":[222],"not":[223],"observe":[224],"any":[225],"both":[229],"arms":[230],"incidence":[232,292,373,384],"acneiform":[234,237,256],"rash,":[235,238],"severe":[236,241,255,279,306,335],"diarrhea,":[239],"diarrhea":[242],"(acneiform":[243],"rash:":[244,257],"1.09,":[247],"0.84\u20131.42,":[251],".51;":[254],"1.50,":[260],"0.80\u20132.81,":[264],".21;":[267],"diarrhea:":[268,280],"1.08,":[271],"0.82\u20131.42,":[275],".58;":[278],"0.90,":[283],"0.44\u20131.84,":[287],".77).":[290],"paronychia":[294,375],"decreased":[296,309,377],"arm,":[300,381],"but":[301],"hypomagnesemia":[304,307,386],"arm.":[313,392],"(paronychia:":[314],"0.74,":[317],"0.55\u20131.00,":[321],".05;":[324],"hypomagnesemia:":[325,336],"1.85,":[328],"=1.41\u20132.41,":[331],"<":[333],".00001;":[334],"2.66,":[339],"1.52\u20134.67,":[343],".0006).Conclusion":[346],"PFS":[354],"RR":[356],"For":[369],"reactions,":[371],"deceased":[388]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4290803826","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-08-12T00:00:00"}
